| Catalog Number |
644611 |
| Medical Device Problem Code |
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/10/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that during use with bd multitest¿ erroneous results were obtained.There was no patient impact.The following information was provided by the initial reporter: tbnk run with 1/3 of patients showing a small percentage of contamination.Tbnk lot 42267 exp 30.06.2024, this bottle was the 1st bottle of 8 which was opened on 29.09.23 for pre-testing.1.Are there erroneous results on patient samples from diagnostic test? (answer: yes).2.Was there any delay of treatment due to the issue? (answer: no).3.If patient samples were redrawn, was there any change or delay of treatment? (answer: n/a, patient samples not redrawn.) 4.Was there any physical harm/injury to the patient due to the issue? (answer: no).
|
| |
|
Additional Manufacturer Narrative
|
|
The following fields have been updated with corrected information: g.1 - reporting office - becton dickinson and company bd biosciences g.1 - reporting office contact - (b)(4) g.1 - manufacturing site contact - (b)(4).H6.Investigation summary: bd acknowledges the customer's experience regarding the indicated failure mode, customer observed a cd3+cd8+cd4- small population dimmer than the cd8+ cluster in the cd3/cd8 dot plot with 6-color bnk reagent part 644611-42267.The cause of the reported issue of a cd3+cd8+ scattered events observed to be dimmer than the cd3+cd8+ cluster population was not determined.The issue can be due to the stickiness of the apc-cy7 tandem fluorophore used to conjugate to cd8 antibody.The material passed all the product specification when release.Performance check of the complaint lot was compared to a reference lot and both lots performed comparably.Bd is continually monitoring complaints received for this device and reported issues to identify emerging trends.
|
| |
|
Event or Problem Description
|
|
It was reported that during use with bd multitest¿ erroneous results were obtained.There was no patient impact.The following information was provided by the initial reporter: tbnk run with 1/3 of patients showing a small percentage of contamination.Tbnk lot 42267 exp 30.06.2024, this bottle was the 1st bottle of 8 which was opened on 29.09.2023 for pre-testing.1.Are there erroneous results on patient samples from diagnostic test? (answer: yes) 2.Was there any delay of treatment due to the issue? (answer: no) 3.If patient samples were redrawn, was there any change or delay of treatment? (answer: n/a, patient samples not redrawn) 4.Was there any physical harm/injury to the patient due to the issue? (answer: no).
|
| |
|
Search Alerts/Recalls
|